NASDAQ:CRNX

Crinetics Pharmaceuticals Stock Insider Trading

etoro logo Buy CRNX
*Your capital is at risk
$33.09
+0.480 (+1.47%)
At Close: Jun 03, 2026

Crinetics Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -30.35. In total, the insiders bought 2.19M and sold 1.45M CRNX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-30.35
Buy 2.19M shares
Sell 1.45M shares
64% Buy Activity
Moderate Negative Correlation
Sell Signal Medium Confidence
Apr 08, 2026

Analysis Breakdown:

  • Supported by a negative Insider Power Score of -30.35.
  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
May 29, 2026
Sell
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 222 200
Value: $0
May 29, 2026
Buy
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 222 200
Value: $7.90M
May 29, 2026
Sell
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 111 100
Value: $0
May 29, 2026
Sell
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 222 200
Value: $0
May 29, 2026
Sell
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 111 100
Value: $0
May 29, 2026
Buy
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 222 200
Value: $7.90M
May 29, 2026
Sell
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 80 000
Value: $0
May 29, 2026
Sell
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 111 100
Value: $0
May 29, 2026
Buy
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 111 100
Value: $3.95M
May 29, 2026
Buy
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 80 000
Value: $2.84M
May 29, 2026
Sell
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 111 100
Value: $0
Apr 08, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Knight Jeff E.
Chief Dev. & Operating Officer
Officer 9 624
Value: $192.7K
Apr 08, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Knight Jeff E.
Chief Dev. & Operating Officer
Officer 49 474
Value: $1.19M
Apr 08, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Knight Jeff E.
Chief Dev. & Operating Officer
Officer 19 336
Value: $379.8K
Apr 08, 2026
Sell
Common Stock
S-Sale
Knight Jeff E.
Chief Dev. & Operating Officer
Officer 85 163
Value: $3.42M
Apr 08, 2026
Buy
Common Stock
M-Exempt
Knight Jeff E.
Chief Dev. & Operating Officer
Officer 49 474
Value: $1.19M
Apr 08, 2026
Buy
Common Stock
M-Exempt
Knight Jeff E.
Chief Dev. & Operating Officer
Officer 9 624
Value: $192.7K
Apr 08, 2026
Buy
Common Stock
M-Exempt
Knight Jeff E.
Chief Dev. & Operating Officer
Officer 19 336
Value: $379.8K
Mar 16, 2026
Sell
Common Stock
S-Sale
Struthers Richard Scott
President & CEO
CEO / President 8 785
Value: $331.8K
Mar 16, 2026
Sell
Common Stock
S-Sale
Betz Stephen F.
Chief Scientific Officer
Officer 6 371
Value: $236.4K
Mar 16, 2026
Sell
Common Stock
S-Sale
Knight Jeff E.
Chief Operating Officer
C-Suite Officer 3 961
Value: $149.6K
Mar 16, 2026
Sell
Common Stock
S-Sale
Knight Jeff E.
Chief Operating Officer
C-Suite Officer 5 950
Value: $220.8K
Mar 16, 2026
Sell
Common Stock
S-Sale
Betz Stephen F.
Chief Scientific Officer
Officer 4 241
Value: $160.2K
Mar 16, 2026
Sell
Common Stock
S-Sale
Struthers Richard Scott
President & CEO
CEO / President 13 196
Value: $489.7K
Mar 12, 2026
Sell
Common Stock
S-Sale
Vivaldi Coelho Rogerio
Director
Director 4 477
Value: $161.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT CRINETICS PHARMACEUTICALS INC
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat c...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE